Clene Inc. SEC filings CLNN

Clene Inc. has 707 filings in SEC EDGAR's recent list, going back to Sep 10, 2020. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Clene Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
4 Insider transaction Oct 21, 2026 Oct 20, 2026
4 Insider transaction Oct 21, 2026 Oct 20, 2026
4 Insider transaction Oct 21, 2026 Oct 20, 2026
8-K Current report
Material agreement
Oct 20, 2026 Oct 15, 2026
8-K Current report
Other events
Oct 19, 2026 Oct 19, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 13, 2026 —
4 Insider transaction Sep 18, 2026 Sep 16, 2026
4 Insider transaction Sep 18, 2026 Sep 16, 2026
4 Insider transaction Sep 18, 2026 Sep 16, 2026
8-K Current report
Material agreement, Other events
Sep 16, 2026 Sep 15, 2026
424B5 Prospectus supplement Sep 16, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
4 Insider transaction Aug 14, 2026 Aug 13, 2026
4 Insider transaction Aug 14, 2026 Aug 13, 2026
4 Insider transaction Aug 14, 2026 Aug 13, 2026
4 Insider transaction Aug 14, 2026 Aug 13, 2026
4 Insider transaction Aug 14, 2026 Aug 13, 2026
4 Insider transaction Aug 14, 2026 Aug 13, 2026
4 Insider transaction Aug 14, 2026 Aug 13, 2026
4 Insider transaction Aug 14, 2026 Aug 13, 2026
8-K Current report
Results of operations
Aug 14, 2026 Aug 14, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 11, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Aug 10, 2026 Aug 10, 2026
4 Insider transaction Aug 6, 2026 Jul 17, 2026
SCHEDULE 13G Ownership over 5% (passive) Aug 4, 2026 —
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
S-8 Employee stock plan registration Jun 5, 2026 —
SD Specialized disclosure (conflict minerals) May 22, 2026 —
8-K Current report
Material agreement, Officer or director change, Shareholder vote results
May 22, 2026 May 18, 2026
4 Insider transaction May 22, 2026 May 21, 2026
4 Insider transaction May 22, 2026 May 21, 2026
4 Insider transaction May 22, 2026 May 21, 2026
4 Insider transaction May 22, 2026 May 21, 2026
4 Insider transaction May 22, 2026 May 21, 2026
4 Insider transaction May 22, 2026 May 21, 2026
4 Insider transaction May 22, 2026 May 21, 2026
4 Insider transaction May 22, 2026 May 21, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2026 —
8-K Current report
Material agreement, Results of operations
May 14, 2026 May 11, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026
4 Insider transaction May 13, 2026 May 11, 2013
SCHEDULE 13G/A Amended ownership over 5% (passive) May 12, 2026 —
144 Notice of proposed sale May 11, 2026 —
4 Insider transaction May 5, 2026 May 1, 2026
8-K Current report
Material agreement, Other events
May 5, 2026 May 5, 2026
424B5 Prospectus supplement May 5, 2026 —
424B5 Prospectus supplement May 5, 2026 —
144 Notice of proposed sale May 4, 2026 —
8-K Current report
Regulation FD disclosure, Other events
May 4, 2026 May 4, 2026
4 Insider transaction Apr 30, 2026 Apr 28, 2026
144 Notice of proposed sale Apr 28, 2026 —
4 Insider transaction Apr 22, 2026 Apr 20, 2026
4 Insider transaction Apr 17, 2026 Apr 15, 2026
144 Notice of proposed sale Apr 15, 2026 —
ARS Annual report to shareholders Apr 10, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 10, 2026 —
DEF 14A Proxy statement Apr 10, 2026 Dec 31, 2025
4 Insider transaction Apr 6, 2026 Apr 2, 2026
4 Insider transaction Apr 1, 2026 Apr 1, 2026
144 Notice of proposed sale Mar 31, 2026 —
4 Insider transaction Mar 31, 2026 Mar 27, 2026
4 Insider transaction Mar 26, 2026 Mar 24, 2026
144 Notice of proposed sale Mar 24, 2026 —
10-K Annual report Mar 17, 2026 Dec 31, 2025
8-K Current report
Material agreement
Mar 17, 2026 Mar 13, 2026
8-K Current report
Results of operations
Mar 12, 2026 Mar 12, 2026
8-K Current report
Other events
Feb 24, 2026 Feb 24, 2026
4 Insider transaction Feb 20, 2026 Feb 19, 2026
4 Insider transaction Feb 20, 2026 Feb 19, 2026
4 Insider transaction Feb 20, 2026 Feb 19, 2026
4 Insider transaction Feb 20, 2026 Feb 19, 2026
4 Insider transaction Feb 20, 2026 Feb 19, 2026
4 Insider transaction Feb 20, 2026 Feb 19, 2026
4 Insider transaction Feb 20, 2026 Feb 19, 2026
4 Insider transaction Feb 20, 2026 Feb 19, 2026
4 Insider transaction Feb 5, 2026 Feb 3, 2026
144 Notice of proposed sale Feb 3, 2026 —
4 Insider transaction Feb 2, 2026 Jan 29, 2026
4 Insider transaction Jan 28, 2026 Jan 26, 2026
4 Insider transaction Jan 23, 2026 Jan 22, 2026
4 Insider transaction Jan 23, 2026 Jan 22, 2026
4 Insider transaction Jan 23, 2026 Jan 22, 2026
4 Insider transaction Jan 23, 2026 Jan 22, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 16, 2026 Jan 13, 2026
4 Insider transaction Jan 13, 2026 Jan 9, 2026
8-K Current report
Material agreement, Other events
Jan 13, 2026 Jan 8, 2026
4 Insider transaction Jan 13, 2026 Jan 13, 2026
4 Insider transaction Jan 12, 2026 Jan 8, 2026
8-K Current report
Other events
Jan 12, 2026 Jan 12, 2026
424B5 Prospectus supplement Jan 9, 2026 —
4 Insider transaction Jan 7, 2026 Jan 5, 2026
4 Insider transaction Jan 2, 2026 Dec 31, 2025
4 Insider transaction Dec 31, 2025 Dec 29, 2025
4 Insider transaction Dec 30, 2025 Dec 23, 2025
25-NSE Delisting notice Dec 30, 2025 —
4 Insider transaction Dec 23, 2025 Dec 19, 2025
4 Insider transaction Dec 18, 2025 Dec 3, 2025
144 Notice of proposed sale Dec 5, 2025 —
8-K Current report
Regulation FD disclosure
Dec 3, 2025 Dec 3, 2025
8-K Current report
Other events
Dec 3, 2025 Dec 3, 2025
4 Insider transaction Nov 14, 2025 Nov 13, 2025
4 Insider transaction Nov 14, 2025 Nov 13, 2025
4 Insider transaction Nov 14, 2025 Nov 13, 2025
4 Insider transaction Nov 14, 2025 Nov 13, 2025
4 Insider transaction Nov 14, 2025 Nov 13, 2025
4 Insider transaction Nov 14, 2025 Nov 13, 2025
4 Insider transaction Nov 14, 2025 Nov 13, 2025
4 Insider transaction Nov 14, 2025 Nov 13, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 13, 2025 —
8-K Current report
Results of operations
Nov 13, 2025 Nov 13, 2025
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Other events
Oct 17, 2025 Oct 17, 2025
424B5 Prospectus supplement Oct 17, 2025 —
8-K Current report
Results of operations, Regulation FD disclosure
Oct 14, 2025 Oct 14, 2025
4/A Form 4/a Sep 30, 2025 Sep 25, 2025
4/A Form 4/a Sep 30, 2025 Sep 25, 2025
4/A Form 4/a Sep 30, 2025 Sep 25, 2025
4 Insider transaction Sep 29, 2025 Sep 25, 2025
4 Insider transaction Sep 29, 2025 Sep 25, 2025
4 Insider transaction Sep 29, 2025 Sep 25, 2025
8-K Current report
Regulation FD disclosure, Other events
Sep 25, 2025 Sep 25, 2025
4 Insider transaction Sep 19, 2025 Sep 18, 2025
4 Insider transaction Sep 19, 2025 Sep 18, 2025
4 Insider transaction Sep 19, 2025 Sep 18, 2025
EFFECT Filing Sep 12, 2025 —
424B3 Prospectus Sep 12, 2025 —
CORRESP Letter to the SEC Sep 10, 2025 —
UPLOAD Letter from the SEC Sep 9, 2025 —
8-K Current report
Other events
Sep 5, 2025 Sep 5, 2025
424B5 Prospectus supplement Sep 5, 2025 —
S-3 Shelf registration Sep 5, 2025 —
S-8 Employee stock plan registration Sep 5, 2025 —
4 Insider transaction Aug 21, 2025 Aug 21, 2025
4 Insider transaction Aug 15, 2025 Aug 14, 2025
4 Insider transaction Aug 15, 2025 Aug 14, 2025
4 Insider transaction Aug 15, 2025 Aug 14, 2025
4 Insider transaction Aug 15, 2025 Aug 14, 2025
4 Insider transaction Aug 15, 2025 Aug 14, 2025
4 Insider transaction Aug 15, 2025 Aug 14, 2025
4 Insider transaction Aug 15, 2025 Aug 14, 2025
4 Insider transaction Aug 15, 2025 Aug 14, 2025
8-K Current report
Material agreement, Results of operations, New debt
Aug 14, 2025 Aug 13, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Other events
Jul 3, 2025 Jul 3, 2025
424B5 Prospectus supplement Jul 3, 2025 —
8-K Current report
Other events
Jun 30, 2025 Jun 30, 2025
8-K Current report
Other events
Jun 17, 2025 Jun 17, 2025
4 Insider transaction Jun 4, 2025 Jun 4, 2025
4 Insider transaction Jun 2, 2025 Jun 2, 2025
4 Insider transaction May 30, 2025 May 30, 2025
4 Insider transaction May 29, 2025 May 29, 2025
4 Insider transaction May 28, 2025 May 28, 2025
4 Insider transaction May 27, 2025 May 27, 2025
8-K Current report
Officer or director change, Shareholder vote results
May 23, 2025 May 21, 2025
4 Insider transaction May 23, 2025 May 22, 2025
4 Insider transaction May 23, 2025 May 22, 2025
4 Insider transaction May 23, 2025 May 22, 2025
4 Insider transaction May 23, 2025 May 22, 2025
4 Insider transaction May 23, 2025 May 22, 2025
4 Insider transaction May 23, 2025 May 22, 2025
4 Insider transaction May 23, 2025 May 22, 2025
4 Insider transaction May 23, 2025 May 22, 2025
SD Specialized disclosure (conflict minerals) May 16, 2025 —
10-Q Quarterly report May 7, 2025 Mar 31, 2025
8-K Current report
Results of operations, Listing notice
May 7, 2025 May 6, 2025
424B5 Prospectus supplement Apr 28, 2025 —
8-K Current report
Material agreement
Apr 28, 2025 Apr 28, 2025
EFFECT Filing Apr 25, 2025 —
CORRESP Letter to the SEC Apr 23, 2025 —
ARS Annual report to shareholders Apr 8, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 8, 2025 —
DEF 14A Proxy statement Apr 8, 2025 Dec 31, 2024
8-K Current report
Regulation FD disclosure, Other events
Apr 8, 2025 Apr 8, 2025
PRE 14A Preliminary proxy statement Mar 28, 2025 Dec 31, 2024
UPLOAD Letter from the SEC Mar 27, 2025 —
424B5 Prospectus supplement Mar 27, 2025 —
8-K Current report
Other events
Mar 27, 2025 Mar 26, 2025
424B5 Prospectus supplement Mar 24, 2025 —
S-3 Shelf registration Mar 24, 2025 —
10-K Annual report Mar 24, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 24, 2025 Mar 24, 2025
4 Insider transaction Mar 19, 2025 Mar 18, 2025
8-K Current report
Other events
Mar 12, 2025 Mar 12, 2025
4 Insider transaction Feb 28, 2025 Feb 27, 2025
4 Insider transaction Feb 28, 2025 Feb 27, 2025
4 Insider transaction Feb 28, 2025 Feb 27, 2025
4 Insider transaction Feb 28, 2025 Feb 27, 2025
4 Insider transaction Feb 28, 2025 Feb 27, 2025
4 Insider transaction Feb 28, 2025 Feb 27, 2025
4 Insider transaction Feb 28, 2025 Feb 27, 2025
4 Insider transaction Feb 28, 2025 Feb 27, 2025
4 Insider transaction Feb 25, 2025 Feb 24, 2025

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CLNN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Salt Lake City, UT
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1822791
Former names
Chelsea Worldwide Inc. (until Dec 18, 2020)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.